Having spent her entire career in the biopharma industry, Patricia currently leads a global team to ensure that patient voice infuses Sanofi’s entire therapeutic portfolio with patient perspectives. This focus ensures that clinical trials and clinical development strategies reflect patient centric objectives which seek to differentiate Sanofi products and the patient experience. Pat’s team is the face of Sanofi R&D to patient advocacy organizations.
Pat closely engages with FDA/EMA industry consortia (such as Patient Focused Drug Development, IMI/EFPIA, etc.) to contribute to and leverage industry trends and policy positions regarding patient-centric initiatives. She sits on the TransCelerate Patient Insights Council and is an active contributor to many other patient-facing industry initiatives including equity, diversity, and inclusion in healthcare.